Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer-Reference-Cited by-同舟云学术

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer

Published:2006-01 Issue:7 Volume:45 Page:779-786
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Timmerman Robert,Galvin James,Michalski Jeff,Straube William,Ibbott Geoffrey,Martin Elizabeth,Abdulrahman Ramzi,Swann Suzanne,Fowler Jack,Choy Hak

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860600902213

Reference17 articles.

1. Preliminary Clinical Experience with Linear Accelerator-based Spinal Stereotactic Radiosurgery

2. Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

3. Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method

4. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients

5. Real-time tumour-tracking radiotherapy

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR);Practical Radiation Oncology;2024-09

2. Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients;Cancers;2024-05-30

3. How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery;American Journal of Clinical Oncology;2024-04-23

4. Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy (LITE-SABR) for Recurrent and/or Metastatic Pediatric Cancers;2024

5. Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers;Clinical Oncology;2023-12